| |
Abstracts of Key Research Articles
Data
integration: challenges for drug discovery
Searls, D.B.
Nature Reviews Drug Discovery, Volume 4, Number 1, pages
45-58
Virtual
ligand screening: strategies, perspectives and limitations
Klebe, G.
Drug Discovery Today, Volume 11, Issues 13-14, pages
580-594
Keynote
review: structural biology and drug discovery
Congreve, M., Murray, C.W., and Blundell, T.L.
Drug Discovery Today, Volume 10, Issue 13, pages 895-907
Biology
calls the targets: combining RNAi and disease biology
Van Es, H.H.G. and Arts, G.-J.
Drug Discovery Today, Volume 10, Issue 20, pages 1385-1391
Foundation
Review: Transgenic animals and their impact on the drug discovery
industry
Dunn, D.A., Pinkert, C.A., Kooyman, D.L.
Drug Discovery Today, Volume 10, Issue 11, pages 757-767
Finding
new drug targets in the 21st century
Lindsay, M.A.
Drug Discovery Today, Volume 10, Issues 23-24, pages
1683-1687
Finding
the target after screening the phenotype
Hart, C.P.
Drug Discovery Today, Volume 10, Issue 7, pages 513-519
Critical
Review of the role of HTS in drug discovery
Macarron, R.
Drug Discovery Today, Volume 11, Issues 7-8, pages 277-79
Combinatorial
biomarkers: from early toxicology assays to patient population
profiling
Koop, R.
Drug Discovery Today, Volume 10, Issue 11, pages 781-788
Less
is more: the human microdosing concept
Garner, R.C.
Drug Discovery Today, Volume 10, Issue 7, pages 449-451
Using
imaging biomarkers to accelerate drug development and clinical
trials
Pien, H.H. et al.
Drug Discovery Today, Volume 10, Issue 4, pages 259-266
Opinion:
Impact of genetic diagnostics on drug development
Million, R.P.
Nature Reviews Drug Discovery, Volume 5, pages 459-462
Challenges
and Opportunities of pharmacogenetics in drug development
March, R.
Future Medicine – Personalized Medicine, Volume
3, Issue 2, pages 195-206
R&D
technology investments: misguided and expensive or a better way
to discover medicines?
Schmid, E.F. and Smith, D.A.
Drug Discovery Today, Volume 11, issues 17-18, pages
775-784 |
